Corporate Advisory Council
Sleep Consortium Corporate Advisory Council (CAC)
The Sleep Consortium Corporate Advisory Council (CAC) is an intentional collaborative community of members committed to improving all lives of those affected by clinically disordered sleep. Designated representatives from external organizations that share the values and aims of Sleep Consortium bring their unique perspectives, experience and challenges to direct progress and outcomes for our patient community across the globe. Patient advocates, academics, clinicians and industry partners who seek answers to questions that will accelerate research in Central Disorders of Hypersomnolence (CDoH) meet quarterly under the aegis and guidance of the Sleep Consortium executive team and expert medical advisory board.
The CAC is intended to shape, lead, and direct the design of new research initiatives, challenge the status quo of current research methodology and engage with the patient community to accelerate therapeutic development and access.
Benefits to participating CAC members include:
- Access to research platforms and all pre-competitive report data
- Participation in conversations with individuals, clinicians, and organizations*
- Opportunities to participate in research platform and consortium data governance development
- One-on-one yearly strategic meetings with Sleep Consortium executive team to identify areas of pressing research*
- Become part of a progressive rare and non-rare community with new data and analytics tools emerging continuously
- Participate in Sleep Consortium ongoing prioritization of tech and global registry development, data governance and the framework for Data Sharing and Access
* Designates Tier 1 membership only
